RFK Jr. Initiates Safety Review of Abortion Pill Amid Federal Scrutiny
TL;DR
RFK Jr. announced that the FDA will review the safety and efficacy of abortion pills, particularly mifepristone, amid political pressure from anti-abortion advocates. This review could lead to restrictions on the most common abortion method in the U.S., potentially impacting access, especially in states with bans. The move has been criticized by reproductive health organizations and advocates for undermining established safety data and access to medication abortion.
- RFK Jr. launches FDA review of abortion pill ABC News - Breaking News, Latest News and Videos
- Federal agencies are studying safety of abortion drug mifepristone, driving new concerns about limits on access CNN
- Trump administration reviewing abortion pill The Hill
- RFK Jr. Opens Investigation Into the Safety of the Abortion Pill Bloomberg.com
- RFK Jr. says FDA will "study" new safety limits on abortion pill Axios
Want the full story? Read the original reporting
Read on ABC News - Breaking News, Latest News and Videos